Greene, Jeff; Purcell, Dennis; Edelman, Brian; … - In: Journal of Applied Corporate Finance 22 (2010) 2, pp. 8-35
In a roundtable published in this journal a year ago, there was a clear consensus that the R&D function in big pharma was inefficient and in need of major restructuring, possibly through increased investments by venture capital and private equity firms. In this discussion, an accomplished group...